A detailed history of Boston Partners transactions in Ashland Global Holdings Inc stock. As of the latest transaction made, Boston Partners holds 392,679 shares of ASH stock, worth $29.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
392,679
Previous 498,533 21.23%
Holding current value
$29.9 Million
Previous $47.1 Million 27.49%
% of portfolio
0.04%
Previous 0.06%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$81.74 - $97.42 $8.65 Million - $10.3 Million
-105,854 Reduced 21.23%
392,679 $34.2 Million
Q2 2024

Aug 13, 2024

BUY
$93.57 - $101.19 $6.49 Million - $7.01 Million
69,313 Added 16.15%
498,533 $47.1 Million
Q1 2024

May 13, 2024

BUY
$78.35 - $97.61 $8.34 Million - $10.4 Million
106,417 Added 32.97%
429,220 $41.8 Million
Q4 2023

Feb 07, 2024

SELL
$72.45 - $87.24 $1.04 Million - $1.25 Million
-14,382 Reduced 4.27%
322,803 $27.2 Million
Q3 2023

Nov 07, 2023

SELL
$80.66 - $92.66 $622,533 - $715,149
-7,718 Reduced 2.24%
337,185 $27.5 Million
Q2 2023

Aug 10, 2023

SELL
$81.95 - $104.44 $1.6 Million - $2.04 Million
-19,579 Reduced 5.37%
344,903 $30 Million
Q1 2023

May 09, 2023

BUY
$95.0 - $112.24 $8.63 Million - $10.2 Million
90,882 Added 33.22%
364,482 $37.4 Million
Q4 2022

Feb 07, 2023

BUY
$93.6 - $113.62 $18 Million - $21.9 Million
192,658 Added 238.02%
273,600 $29.4 Million
Q3 2022

Nov 09, 2022

SELL
$93.76 - $108.38 $1.47 Million - $1.7 Million
-15,658 Reduced 16.21%
80,942 $7.77 Million
Q2 2022

Aug 10, 2022

BUY
$94.81 - $110.51 $2.4 Million - $2.8 Million
25,358 Added 35.59%
96,600 $9.95 Million
Q1 2022

May 10, 2022

BUY
$85.05 - $106.34 $6.06 Million - $7.58 Million
71,242 New
71,242 $7.01 Million

Others Institutions Holding ASH

About ASHLAND GLOBAL HOLDINGS INC


  • Ticker ASH
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 54,139,400
  • Market Cap $4.13B
  • Description
  • Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubili...
More about ASH
Track This Portfolio

Track Boston Partners Portfolio

Follow Boston Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.